Cited by 187Hypothalamic control of reproductive hormonesDiabetes, Cardiovascular Risks, and LipoproteinsCancer Risks and Factors

Age at Menarche and Type 2 Diabetes Risk

Open access
Elks, Cathy E., Ong, Ken K., Scott, Robert A., van der Schouw, Yvonne T., Brand, Judith S., Wark, Petra A., Amiano, Pilar, Balkau, Beverley +30 more·2013·Diabetes Care

Abstract

OBJECTIVE: Younger age at menarche, a marker of pubertal timing in girls, is associated with higher risk of later type 2 diabetes. We aimed to confirm this association and to examine whether it is explained by adiposity. RESEARCH DESIGN AND METHODS: The prospective European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study consists of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 individuals from 26 research centers across eight European countries. We tested the association between age at menarche and incident type 2 diabetes using Prentice-weighted Cox regression in 15,168 women (n = 5,995 cases). Models were adjusted in a sequential manner for potential confounding and mediating factors, including adult BMI. RESULTS: Mean menarcheal age ranged from 12.6 to 13.6 years across InterAct countries. Each year later menarche was associated with 0.32 kg/m2 lower adult BMI. Women in the earliest menarche quintile (8-11 years, n = 2,418) had 70% higher incidence of type 2 diabetes compared with those in the middle quintile (13 years, n = 3,634), adjusting for age at recruitment, research center, and a range of lifestyle and reproductive factors (hazard ratio [HR], 1.70; 95% CI, 1.49-1.94; P < 0.001). Adjustment for BMI partially attenuated this association (HR, 1.42; 95% CI, 1.18-1.71; P < 0.001). Later menarche beyond the median age was not protective against type 2 diabetes. CONCLUSIONS: Women with history of early menarche have higher risk of type 2 diabetes in adulthood. Less than half of this association appears to be mediated by higher adult BMI, suggesting that early pubertal development also may directly increase type 2 diabetes risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc13-0446

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Elks, C. E., Ong, K. K., Scott, R. A., van der Schouw, Y. T., Brand, J. S., Wark, P. A., Amiano, P., Balkau, B., Barricarte, A., Boeing, H., Fonseca-Nunes, A., Franks, P. W., Grioni, S., Halkjaer, J., Kaaks, R., Key, T. J., Khaw, K. T., Mattiello, A., Nilsson, P. M., Overvad, K., Palli, D., Quirós, J. R., Rinaldi, S., Rolandsson, O., Romieu, I., Sacerdote, C., Sánchez, M.-J., Spijkerman, A. M. W., Tjonneland, A., Tormo, M.-J., Tumino, R., van der A, D. L., Forouhi, N. G., Sharp, S. J., Langenberg, C., Riboli, E., Wareham, N. J., & The InterAct Consortium
Affiliations
  • University of Cambridge (GB)
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
  • University Medical Center Utrecht (NL)
  • Imperial College London (GB)
  • Basque Government (ES)
  • Université Paris-Sud (FR)
  • Instituto de Salud Pública de Navarra (ES)
  • German Institute of Human Nutrition (DE)
  • Department of Epidemiology, Nutrition, Environment, and Cancer Unit, Catalan Institute of Oncology, L'Hospitalet de Lolgbregat, Barcelona, Spain
  • Lund University (SE)
  • Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
  • Danish Cancer Society Research Center, Copenhagen, Denmark
  • German Cancer Research Center (DE)
  • University of Oxford (GB)
  • Federico II University Hospital (IT)
  • Aarhus University (DK)
  • Istituto per lo Studio e la Prevenzione Oncologica (IT)
  • Consejería de Sanidad, Public Health Directorate, Oviedo-Asturias, Spain
  • Centre international de recherche sur le cancer (FR)
  • Umeå University (SE)
  • Italian institute for Genomic Medicine (IT)
  • Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
  • National Institute for Public Health and the Environment (NL)
  • Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública), Madrid, Spain
  • Azienda Usl 8 Arezzo (IT)
  • National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
  • Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St. Mary’s Campus, Norfolk Place, London, U.K.
Corresponding author
Elks, Cathy E.
Venue
Diabetes Care
Published
2013-10-15
Volume
36
Issue
11
Pages
3526-3534
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1978720848
Cited by
186
References
40
Citations by year
2026: 8 · 2025: 14 · 2024: 22 · 2023: 10 · 2022: 15 · 2021: 17 · 2020: 19 · 2019: 11 · 2018: 16 · 2017: 14 · 2016: 15 · 2015: 14 · 2014: 10
FWCI
15.70
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
  • Pure (Coventry University) (submittedVersion)
  • Rivm (National Institute for Public Health and the Environment) (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135)
  • Medical Research Council (MC_UU_12015/5, MC_UU_12015/2, MC_UU_12015/1)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
age at menarche, type 2 diabetes, pubertal timing, adult body mass index, adiposity, women, incident diabetes risk
MeSH terms
Adult, Age Factors, Diabetes Mellitus, Type 2, Europe, Female, Humans, Life Style, Longitudinal Studies, Menarche, Middle Aged, Neoplasms, Obesity, Prospective Studies, Risk, Risk Factors, Incidence, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review